Related Experiment Videos
Emerging infectious diseases--a therapeutic challenge
Expert Opinion on Pharmacotherapy
|March 16, 2001
Summary
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
The treatment of tuberculosis: current status and future prospects.
Expert opinion on investigational drugs·2005
Ribavirin--current status of a broad spectrum antiviral agent.
Expert opinion on pharmacotherapy·2001
Current management of tuberculosis.
Expert opinion on pharmacotherapy·2001
New developments in the treatment of viral respiratory tract infections.
Expert opinion on investigational drugs·1997
Do sigma-1 receptor agonists offer therapeutic promise for Alzheimer's disease?
Expert opinion on pharmacotherapy·2026
Gepotidacin in oral antibacterial pharmacotherapy: efficacy, safety, and clinical positioning.
Expert opinion on pharmacotherapy·2026
Low-dose Colchicine for atherosclerotic cardiovascular disease and the return of inflammation-targeted Pharmacotherapy.
Expert opinion on pharmacotherapy·2026
Current perspectives on β<sub>2</sub>-adrenergic receptor agonists in asthma: navigating from track to track within GINA recommendations.
Expert opinion on pharmacotherapy·2026
Beyond the primary endpoint: what VICTOR really tells us about vericiguat.
Expert opinion on pharmacotherapy·2026
Current and emerging pharmacotherapy for rosacea: a misunderstood and undertreated condition.
Expert opinion on pharmacotherapy·2026
Development of a Novel, Eco-Friendly Mechanical Cell Lysis Process Using Hollow Fiber Filter for AAV Manufacturing.
Biotechnology and bioengineering·2026
Programmed repair of disease-causing UGA premature termination codons in mammalian brain.
Nucleic acids research·2026
Molecular profiling and functional analyses of umbilical cord mesenchymal stem cell-derived extracellular vesicles for dry eye diseases.
Extracellular vesicles and circulating nucleic acids·2026
Immunotherapy for tuberculosis: current landscape, mechanistic insights, and translational perspectives.
Frontiers in immunology·2026
Real-World Effectiveness and Safety of Tildrakizumab in Patients With Moderate-to-Severe Psoriasis After Failure of Ustekinumab: A Multicenter Retrospective Study.
The Journal of clinical and aesthetic dermatology·2026